Literature DB >> 32191673

Nasal cytology identifies healthy and damaged nasal epithelial cells - Reply.

Giorgio Ciprandi1, Matteo Gelardi2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32191673      PMCID: PMC7569582          DOI: 10.23750/abm.v91i1.9264

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


× No keyword cloud information.
To the Editor, we would like to thank Rafael Martínez-Girón, Hugo Cornelis van Woerden, and Cristina Martínez-Torre, who confirmed post-viral, namely during rhinovirus infection, cytomorphological alterations loaded to nasal epithelial cells (1). The outcomes of that study were consistent with our research that described structural modification during viral infection (2,3). In this regard, the first evidence concerned vacuolar degeneration at the cytoplasmic level and further nuclear impairment, manly nuclear alterations, such as intranuclear halo (4). In particular, it has to note that the “halo” is inside the cellular membrane as confirmed by electronic microscopy (3). Analyzing the subjects investigated by the authors, it seems that some relevant details were lacking, mainly concerning the type of perennial rhinitis. In fact, as reported, all subjects were treated with oral H1 antagonists and intranasal corticosteroids. Both medications are commonly prescribed for allergic rhinitis. Besides, 2 patients had nasal polyps and one asthma. There is a reasonable suspicion that they suffered from allergic rhinitis. In conflict with this hypothesis, eosinophils were, however, very scarce. Remarkably, perennial rhinitis was not classified in their study. Consistently, we would underline the clinical relevance of nasal cytology in the workup of nasal disorders (5). Nasal cytology is a simple, easy, and repeatable technique that is very fruitful in clinical practice. Nasal cytology carefully defines the phenotype and endotype of rhinitis, so it is a classic example of Precision Medicine (6) and it is a point-of-care test (7). Moreover, it has been recently standardized, thus the methodology has been rigorously validated (8). In the context of the topic, a close link exists between allergic rhinitis and rhinovirus. It was demonstrated that allergic patients have a mucosal inflammation that involves adhesion molecule machinery, mainly intercellular adhesion molecule 1 (ICAM-1), and is associated with functional impairment, such as nasal airflow limitation (9-11). Interestingly, ICAM-1 is also the main receptor for rhinovirus: this curious coincidence explains the increased susceptibility to infections in allergic patients (12). These concepts underline the importance of a precise and documented diagnosis of rhinitis that is the requisite for a tailored treatment: the so-called Personalized Medicine (13). In conclusion, nasal cytology could be envisaged as a mandatory test to identify the phenotype, and endotype to optimize the management of patients with perennial rhinitis.
  12 in total

1.  Standardization of nasal cytologic testing in the workup of allergic rhinitis.

Authors:  Giorgio Ciprandi; Michela Silvestri
Journal:  Ann Allergy Asthma Immunol       Date:  2019-05-15       Impact factor: 6.347

2.  Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization.

Authors:  G Ciprandi; G L Marseglia; C Klersy; M A Tosca
Journal:  Allergy       Date:  2005-07       Impact factor: 13.146

Review 3.  Role of nasal cytology.

Authors:  M Gelardi; M L Fiorella; C Russo; R Fiorella; G Ciprandi
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Jan-Mar       Impact factor: 3.219

4.  Allergic patients have more numerous and prolonged respiratory infections than nonallergic subjects.

Authors:  I Cirillo; G Marseglia; C Klersy; G Ciprandi
Journal:  Allergy       Date:  2007-06-18       Impact factor: 13.146

Review 5.  Emerging drugs for the treatment of perennial allergic rhinitis.

Authors:  Amelia Licari; Riccardo Castagnoli; Chiara Bottino; Alessia Marseglia; GianLuigi Marseglia; Giorgio Ciprandi
Journal:  Expert Opin Emerg Drugs       Date:  2016-01-25       Impact factor: 4.191

6.  Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow.

Authors:  Giorgio Ciprandi; Ignazio Cirillo; Andrea Vizzaccaro; Manlio Milanese; Maria Angela Tosca
Journal:  Int Arch Allergy Immunol       Date:  2004-03-25       Impact factor: 2.749

7.  Ciliated nasal epithelial cells damage and human rhinovirus infection: cytological findings.

Authors:  Rafael Martinez-Giron; Hugo Cornelis Van Woerden; Cristina Martínez-Torre
Journal:  Acta Biomed       Date:  2020-03-19

Review 8.  ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation.

Authors:  G W Canonica; G Ciprandi; G P Pesce; S Buscaglia; F Paolieri; M Bagnasco
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

9.  Viruses and bacteria in the etiology of the common cold.

Authors:  M J Mäkelä; T Puhakka; O Ruuskanen; M Leinonen; P Saikku; M Kimpimäki; S Blomqvist; T Hyypiä; P Arstila
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

10.  Ciliocytophthoria of nasal epithelial cells after viral infection: a sign of suffering cell.

Authors:  Matteo Gelardi; Giorgio Ciprandi
Journal:  Acta Biomed       Date:  2019-01-14
View more
  1 in total

1.  Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.

Authors:  Matteo Gelardi; Eleonora Trecca; Michele Cassano; Giorgio Ciprandi
Journal:  Acta Biomed       Date:  2020-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.